Oncocyte Corporation
OCX
Market Cap$75.79M
Close$
$-1.65
151.7% downside
Current Fair Value
151.7% downsideOvervalued by 151.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $75.79 Million |
|---|---|
| Enterprise Value | $50.52 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.66 |
| Beta | 0.99 |
| Outstanding Shares | 25,694,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.17 |
|---|---|
| PEG | 4.34 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 13.14 |
| Enterprise Value to EBIT | -0.86 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.56 |
Revenue Sources
No data
Insider Trades
ESG Score
No data